Platelet-Rich Fibrin in the Treatment of Multiple Gingival Recessions
Gingival Recessions
About this trial
This is an interventional treatment trial for Gingival Recessions focused on measuring Platelet rich fibrin, Gingival Recession
Eligibility Criteria
Inclusion Criteria:
- non smoking,
- similar bilateral Miller Class I or II20 localized gingival recessions at least ≥3 mm, located on incisors, canines or premolars on both jaws,
- identifiable cemento-enamel junction (CEJ),
- age ≥18 years,
- presence of tooth vitality and absence of restorations and superficial caries in the area to be treated,
- no periodontal surgical treatment on the involved sites,
- sufficient palatal donor tissue at least ≥2.5 mm thickness for the indicated SCTG
Exclusion Criteria:
- Patients in a pregnancy or lactation period or with self-reported history of antibiotic medication within 6 months
- Molar, mobile or fully restorated teeth
Sites / Locations
- NEU Dental School
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Test groups.
Control groups.
This clinical study was designed as a split-mouth, randomized, controlled clinical trial. Bilateral gingival recession defects were randomly assigned to the test (CAF+PRF) or the control (CAF+SCTG) groups with the use of computer-generated randomization table after assessment of clinical parameters at baseline.
This clinical study was designed as a split-mouth, randomized, controlled clinical trial. Bilateral gingival recession defects were randomly assigned to the test (CAF+PRF) or the control (CAF+SCTG) groups with the use of computer-generated randomization table after assessment of clinical parameters at baseline.